After completing this activity, pharmacists should be able to:
- explain the benefits and harms of antihypertensive medicines;
- identify patients likely to benefit from deprescribing antihypertensive medicines;
- describe the process of deprescribing antihypertensive medicines.
The 2016 Competency Standards addressed by this activity include: 1.5, 2.2, 2.3, 3.1, 3.2, 3.3, 3.5
Accreditation number: CX20002 Accreditation expires: 01/02/2022
This activity has been accredited for 1.0 hour of Group One CPD (or 1.0 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 1.0 hour of Group Two CPD (or 2.0 CPD credits) upon successful completion of the associated assessment activity.